🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Panamá, sede del congreso de la Sociedad Latinoamericana de Infectología Pediátrica (SLIPE) para el año 2027. Un logro que nos enorgullece como sociedad científica y como país. Rolando Ulloa-Gutierrez María L. Avila-Agüero Xavier Sáez Llorens Dora Estripeaut

While the rest of the world deliberates about the logistics of introducing maternal immunisation against RSV, or nirsevimab (a long lasting anti-RSV monoclonal antibody) Galicia in NW Spain has cracked on with giving nirsevimab to all newborns What is really impressive ... 1/n

Just published! The first paper ever! on the real world implementation of nirsevimab as universal prophylaxis against RSV. Data from Galicia (Spain) showing its implementation plan and first coverage results eurosurveillance.org/content/10.280… Eurosurveillance #NIRSEGAL Xunta de Galicia Consellería de Sanidade

Impressive “real world” data on the reduction of RSV- hospitalizations in infants with the universal implementation of nirsevimab in Galicia, Spain!

Nirsevimab funciona. Ultimos resultados de Galicia (Semana 51 - 24-12-23) disponibles en nirsegal.es #nirsegal y sergas.gal/Saude-publica/… mostrando en mundo real el impacto sobre VRS de la inmnunizacion universal de lactantes con nirsevimab 👇👇👇👇 1/x

IDSA is pleased to announce our partnership w/ Febrile! Febrile uses consult questions to dive into ID clinical reasoning, diagnostics and antimicrobial management. We look forward this partnership and expanding awareness about the field of ID. #ValueofID

Mensajes para casa de los representantes españoles en ReSViNET

Fascinating discussion on mucosal immunity at #RSVVW24. My friend Jose Gomez Rial , an expert person on the topic, would instantly fall in love with Felicity Liew and her data! Great discussion with Asun Mejias, Marta Nunes and Caterina Rizzo

Patients with serious infections who are cared for by an ID physician have better outcomes, shorter hospital stays & lower healthcare costs, shares Congressman Raul Ruiz, M.D. during today's House Appropriations and House Appropriations Democrats "Member Day" hearing. Thank you for your leadership in urging

“Since 1974, vaccination has averted 154 million deaths, including 146 million among children younger than 5 years of whom 101 million were infants younger than 1 year.”

🚨👀 Ana M Quintero (1 of PIDS first RAPID awardees) will present results from her project today (May 4) at 2:45-3:00 in 201 AD. Stop by to see and congratulate Ana on ‘Impact of SARS-CoV-2 variants on mucosal cytokines and clinical outcomes in children with COVID-19’ #PAS2024

A recent study identified distinct age-dependent antibody responses that correlate with disease severity, providing targets to aid the design of future vaccine clinical trials. Read the paper in Immunity. ow.ly/ztOo50SWiBw

So, so well deserved- Big congrats Pablito!

Infección respiratoria aguda grave por virus respiratorio sincicial en menores de 1 año, Chile. Años 2019, 2023 y año actual 2024 (en que niños <6 meses recibieron Nirsevimab)

🩺 Debate clave sobre el VRS: 🔹 Futuro del VRS (2025): Dra. Asunción Mejías. 🔹 Prevención con Nirsevimab: Dra. Lucía López (AEP). 🔹 Datos en Andalucía: Dr. Jorge del Diego (Consejería de Salud y Consumo).

Asuncion is the new President of the International RSV Society! So pleased that she was elected to be my successor 😀

I am honored and thankful to you Peter- ReSViNETRSVPatientNetwork PIDS St. Jude Research ReSViNET isirv antiviral

2. Humans and Televisions over the Years

Alguien en Malaga centro que sepa si ha venido la luz?- estoy preocupada por mis padres